Barclays PLC (ATII) discloses 3.88% passive stake in Archimedes Tech SPAC Partner
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Barclays PLC filed an amended Schedule 13G to report its beneficial ownership in Archimedes Tech SPAC Partner common stock. Barclays reports beneficial ownership of 1,148,590 common shares, representing 3.88% of the outstanding class as of the reported date.
Barclays states it has sole voting and sole dispositive power over all 1,148,590 shares, with no shared voting or dispositive power. The filing confirms that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
Positive
- None.
Negative
- None.
FAQ
What does Barclays PLC report in this Schedule 13G/A for ATII?
Barclays PLC reports beneficial ownership of Archimedes Tech SPAC Partner common stock. It holds 1,148,590 shares, equal to 3.88% of the class, with sole voting and dispositive power, underlining a passive, ordinary-course investment position rather than an attempt to influence corporate control.
What percentage of ATII’s common stock is held by Barclays PLC?
Barclays PLC’s position represents 3.88% of Archimedes Tech SPAC Partner’s outstanding common stock. This percentage keeps Barclays below the 5% threshold, and the filing notes that the holding is reported as ownership of 5 percent or less of the class.
Is Barclays PLC seeking control of Archimedes Tech SPAC Partner?
Barclays PLC states the shares were acquired and are held in the ordinary course of business. It explicitly certifies they were not acquired and are not held to change or influence control of Archimedes Tech SPAC Partner, indicating a passive investment stance.